Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Targeted therapies are expensive treatments. In the US, Herceptin sells for $64,000 per year (Source: Genentech) and the annual cost of Avastin is $55,000 to more than $80,000 per year, depending on income.If Prolanta could achieve a 5% market share of the US and European prevalence of ovarian cancer, at least $35,000 per patient per year, revenues would surpass $1 billion per year.
I am sure that Mallinckrodt has facilities and/or drugs that Oncolix needs to move forward to Phase 2 or rolling Phase 3 and probably has seen positive results from Phase 1. I believe that is the exact reason Mallinckrodt has taken a stake.
Mallinckrodt will speak to Oncolix in report results on Feb 26. Boom! GLTA!!!
Yes there is a cap, 10%. Then different documents must be filed and voting rights have to be discussed. An entirely new realm of ownership.
"the Reporting Persons’ beneficial ownership represented 9.6% of the outstanding share of Common Stock"
This 13g was for 8.8%. They already owned .8% prior to this 13g.
Corrected Mallinckrodt percentage of Oncolix is 9.6%, not 8.8%. They already held a position prior to this 13g.
GLTA!!!
1st testing group was 100% successful. 2nd testing group has issues with 2 patients. Awaiting 1st testing group results, and they look healthy with the 8.8% stake by Mallinckrodt. There was no 8K in November.
FAKE news! And there wasn't even an 8K in November. Go away, you look stupid.
MAXM backed way up LOL Couldn't last long like I said. Next move is only one direction...UP!
GLTA!!!
MAXM playing straight up games. Won't last long!
Got that right! Could be too logical though for most to understand LOL
Covering. Not gapping down.
Yes, clinical trials release this month. It's on the website. They are preparing for it.
PR coming! Oncolix has an FDA-cleared IND to commence the Phase I study of Prolanta to treat ovarian cancer. Furthermore, Prolanta was granted orphan designation by the FDA for the treatment of ovarian cancer. Because of the unmet medical needs in ovarian cancer, Oncolix will seek accelerated approval after the Phase IIb study, or will roll the Phase IIb results into a Phase III study. Studies in other indications (breast, endometrial cancer and others) are deferred until later in the clinical development process unless the Company receives additional funding (which they did) to commence these trials or the Company enters into a strategic partnership with a large pharmaceutical company.
That large pharmaceutical partnership is Mallinckrodt & BioVectra, they have everything Oncolix needs for the Phase 2B and/or rolling 3, that is the reason for the 8.8% stake.
Targeted therapies are expensive treatments. In the US, Herceptin sells for $64,000 per year (Source: Genentech) and the annual cost of Avastin is $55,000 to more than $80,000 per year, depending on income.If Prolanta could achieve a 5% market share of the US and European prevalence of ovarian cancer, at least $35,000 per patient per year, revenues would surpass $1 billion per year.
The exact reason Mallinckrodt has taken a stake. Clinical trials about to hit the wires.
Study Start Date : February 2016
Estimated Primary Completion Date : February 2019
Estimated Study Completion Date : February 2019
GLTA
Mallinckrodt beneficially owns BioVectra, and according to 13g, any shares owned by BioVectra are deemed owned by Mallinckrodt. A little confusing, but Mallinckrodt owns everything even if they don't directly own any shares.
BiioVectra and Mallinckrodt http://www.biovectra.com & http://www.mallinckrodt.com if anyone wants to do DD on these monster companies. Can't wait to hear the news of why Mallinckrodt now owns 8.8% stake in Oncolix. BIG things ahead, no doubt about it!
GLTA!!!
That's what happens when a Billion $ NYSE company is a stake holder and something big is about to happen. GL!!!
And could all happen in a short amount of time. GL!
Going back to levels when BioVectra use to have a stake, over .10
Something BIG is brewing, no question about it. GLTA!!!
BioVectra Inc., an indirect wholly-owned subsidiary of Mallinckrodt plc now owns 8.8% of ONCX
Last time BioVectra, Inc was involved, Oncolix, Inc ticker was trading above .10
GLTA!
Keeping an eye on Abina with hotels, commercial and resort properties, the Venture Capital company and the Software company. Looks like we have filings now in Delaware. Could be something with the R/M companies, but I have requested more information from Delaware Secretary of State. Will report more as it comes in.
GLTA!!!
As of Friday 2/8/19:
Market cap $1.6M
Authorized 150,000,000
Outstanding 81,145,933
Restricted 51,000,342
Unrestricted 30,145,591
Looks like we have filings now in Delaware. I have requested more information from Delaware Secretary of State.
Keeping an eye on the Venture Capital company, Software company and Abina investment company in hotels, commercial and resorts. Will report more as it comes in.
GLTA!!!
According to the Eighth Judicial District Court, still confirmed hearing 8:30am on 2/13.
NVOS updated Tommy Chu and Xu Mei marked as Historical. Only Richard Chiang marked Active now on https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=Wq21EZCR%252f2g0q0pFwQF3hg%253d%253d
Eighth Judicial District Court confirmed hearing 8:30am on 2/13.
GLTA!!!
Right into the hands of the MM's, then the MM's build their walls even bigger and we don't get where we need without volume. These traders need a different hobby.
ASCM keeps adjusting the price higher and higher. RSI is cooled off to it's lowest levels in a long time...up we go from here. GLTA!
Huge RSI re-set. Here comes a big movement up! GLTA!
Today could see the largest % gain of this ticker yet. 2 merger candidates are both multi-million dollar profit generating companies. We will know more after the custodianship. Everything will be updated once that is released. Until then, enjoy the ride IMO! GLTA!!!
RSI at it's coolest level in a long time. Get ready for this to possibly rocket north before the close.
RSI can't cool off, not many shares available or being given up. RSI will remain between 60 and 90 all day and run for a LONG time!
GLTA!!!
NVSOS updated with Richard Chiang titled Active
Custodianship by Richard Chiang 2/13/19 -
List of officers due 3/31/19 -
https://www.nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=Wq21EZCR%252f2g0q0pFwQF3hg%253d%253d
GLTA!
Separate merger same CEO from LCTZ - Richard Chiang will be bringing a multi-million dollar company, that is all he deals with. This isn't going to be some fly-by-night type deal or debt ridden company he will strap in here. GLTA!
There isn't even 100K on each Ask before it ticks up. So the limit is maxed and more shares will have to be brought separately, as we are seeing.
RICHARD CHIANG will take custodianship. Same CEO from LCTZ. Then filings will take place, any/all merger information will then be announced as well as any changes to the ticker. We will have to wait for all of that information until after the court date. GL!
Can't sticky it, it's more than 48 hours old. Put together another post with everything and I will sticky it. GL!
LCTZ & CNHC same CEO both confirmed R/M
GLTA!!!
And we're right at the beginning. No chase for us. I am just going to sit back and enjoy this ride, even if it takes a few days. Glad my money is tied up here. GL!
GREAT! Super early jump on this. Hope you make big $$$ I was in on LCTZ yesterday from the beginning of that big run, put all that into this.